<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We analyzed the clinical and biological characteristics as well as the clinical course and outcome observed in 20 patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and clinical signs including <z:mp ids='MP_0005048'>thrombosis</z:mp> or repeated <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> to better identify the recently described <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We retrospectively studied <z:hpo ids='HP_0000001'>all</z:hpo> patients observed in our unit from 1981 to 1992 who fulfilled the following inclusion criteria: a) at least one episode of arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and/or repeated <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo>, b) positive for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Twenty patients were included, 3 with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (according to the American <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">Rheumatism</z:e> Association criteria) </plain></SENT>
<SENT sid="3" pm="."><plain>Arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> occurred in 9 and 16 respectively, including exceptional cases of cerebral <z:mp ids='MP_0010140'>phlebitis</z:mp> and <z:mp ids='MP_0005048'>thrombosis</z:mp> of dermal capillaries </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0002842'>High blood pressure</z:mp> was recorded in 8 </plain></SENT>
<SENT sid="5" pm="."><plain>Only 1 or 2 types of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> were found in most patients </plain></SENT>
<SENT sid="6" pm="."><plain>Anticardiolipin, a circulating <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and a false-positive Bordet-Wassermann reaction were found together in only 3 out of 16 </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, the antibody level varied independently from the thrombotic events </plain></SENT>
<SENT sid="8" pm="."><plain>There was no case with a clinical course from <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> to systemic erythromatosus <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The effect to treatment on occurrence of new thrombotic events was studied </plain></SENT>
<SENT sid="10" pm="."><plain>Three patients suffered one or more haemorrhagic events during antivitamin K treatment </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: It is difficult to establish a differentiation between <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e>, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and <z:e sem="disease" ids="C0919715" disease_type="Disease or Syndrome" abbrv="">lupus-like syndromes</z:e>, and precise methods of identifying <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> should be further developed </plain></SENT>
</text></document>